Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix Product Platform : vimarsana.com

Key patent on implantable tissue repair devices granted in major economies OXFORD, England, July 13, 2022 /PRNewswire/ -- Orthox Limited, a clinical stage company developing medical implants

Related Keywords

Germany , Australia , Bristol , City Of , United Kingdom , Budapest , Hungary , China , Oxfordshire , France , Australian , Hungarian , Nick Skaer , Orthox Fibrofix , Michael Whitehouse , International Orthopaedics , Biomedical Catalyst Fund Award , Scius Communications , Bristol Biomedical Research Centre , Department Of Health , Wellcome , Stage Product Development , Prnewswire Orthox , University Of Bristol , Oxford University , European Innovation Council , United Kingdom Innovation Agency , Orthox Ltd , National Institute For Health , Care Research , Agency For Healthcare Research , National Institute , Wellcome Trust , Southmead Hospital , North Bristol , Fibrofix Cartilage , Study Chief Investigator , Biomedical Research Centre , Healthcare Research , Translation Awards , Late Stage Product Development Awards , Innovation Agency , United Kingdom Aid , Biomedical Research , Orthox , Nnounces , Hra , Uthorisation , Linical , Rial , Nee , Artilage , Epair , Ibrofix , Roduct , Latform ,